People in the U.S. now have access to a second drug that can slow the progression of Alzheimer’s disease. Health reporter Katherine Ward has more on how it works, and when Canadians might get access.
Health
FDA approves 2nd Alzheimer’s drug that slows progression of disease
More Videos
-
Advocates challenge Doug Ford’s policy against safe consumption sites in Ontario
-
Health Matters: Germany to donate 100,000 mpox vaccines to combat outbreak
-
Tips for making healthy back-to-school lunches
-
Scientists launch 1st lung cancer vaccine clinical trials using COVID-19 mRNA technology
-
Canada limits sale of nicotine pouches to pharmacies
-
The surprising truth about aging and caffeine
You are viewing an Accelerated Mobile Webpage.
View Original Article